Erick J. Lucera

Erick J. Lucera serves as the Chief Financial Officer at Dyne Therapeutics since March 2025 and has been a Board Member at SAb Biotherapeutics since March 2023. Additionally, Lucera is a member of the Board of Directors at Beyond Air® and has held multiple CFO positions, including roles at Editas Medicine, AVEO Oncology, and Valeritas, contributing to significant company milestones such as NASDAQ listings and successful financing efforts. Lucera began a career in corporate development with experience at Aratana Therapeutics and Sunshine Heart, and prior experience includes a role as a VP Healthcare Analyst at Eaton Vance. Educational qualifications include advanced degrees in Public Health, Quantitative Finance, and Finance from prestigious institutions such as Harvard University, Boston College, and Indiana University Bloomington, along with a Bachelor's Degree in Accounting from the University of Delaware.